June 21, 2019

Around the nation: Geisinger names Jaewon Ryu permanent president and CEO

Daily Briefing

    Ryu took over as interim president and CEO last December, following David Feinberg's departure to Google, in today's bite-sized hospital and health industry news from Colorado, Massachusetts, and Pennsylvania.

    • Colorado: The Federal Trade Commission (FTC) has signed off on UnitedHealth Group's proposed $4 billion acquisition of DaVita Medical Group. The acquisition was first announced in December 2017, but was met with scrutiny from regulators in part because of a concern of a monopoly in Las Vegas. FTC's approval is contingent upon divestitures of a health plan network in the Las Vegas area. (Daily Briefing is published by Advisory Board, a division of Optum, which is a wholly owned subsidiary of UnitedHealth Group) (Japsen, Forbes, 6/19).

    • Massachusetts: Eric Rubin, an infectious disease specialist at the Harvard T.H. Chan School of Public Health, has been named the new editor-in-chief for the New England Journal of Medicine. Rubin succeeds Jeffrey Drazen, who announced his retirement last year and served as the journal's editor-in-chief since 2000 (Massachusetts Medical Society release, 6/19).

    • Pennsylvania: Geisinger Health on Thursday announced that interim CEO Jaewon Ryu will take over as permanent president and CEO. Ryu, who previously had served as EVP and CMO since 2016, took over as interim president and CEO last December, following David Feinberg's departure to Google. Ryu said he plans to build on Geisinger's programs related to home care, nutrition, transportation, DNA sequencing, and more (Kacik, Modern Healthcare, 6/20).

    How to pick your next leader

    Need to fill a new role on your team? Don't wait until it's too late. Use this infographic to help you build an effective succession planning process.

    Download the Infographic

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.

    X
    Cookies help us improve your website experience. By using our website, you agree to our use of cookies.